PubPeer: Pathologist Threatening to Sue Users

The forum’s founders have obtained legal counsel and are preparing for the possibility of user information being subpoenaed as part of a lawsuit.

Written byKate Yandell
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, BRIAN TURNERThe post-publication peer review forum PubPeer, which last month announced it was being threatened with legal action, today (September 22) released additional details about the alleged “legal threat.” PubPeer’s founders have received three letters objecting to comments made on the site from Nicholas Roumel, a Michigan-based attorney, written on behalf of pathologist Fazlul Sarkar of the Wayne State University School of Medicine. The forum’s founders also announced the site is being represented pro bono by San Francisco-based attorney Nicholas Jollymore. Jollymore told The Scientist there have been no formal legal proceedings at this point.

There are dozens of threads posted to PubPeer discussing Sarkar’s work. In an e-mail to The Scientist, Roumel wrote: “I am concerned about many posts and may begin legal action against anonymous commenter(s). That may lead me to subpoena information from PubPeer. As to whether I have independent grounds to sue PubPeer itself, while I do not rule that out in the future, I don’t have sufficient facts and law on my side to do that right now. That may change depending on what is uncovered.” Sarkar did not respond to The Scientist’s requests for comment.

Roumel said that the anonymous comments on PubPeer cost Sarkar a tenured position at the University of Mississippi, where he had accepted a job offer. Two weeks before he ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies